Members

• 

  増永　辰弥Tatsuya Masunaga Recruiting Advisor

  大手人材サービス企業にて新規開拓営業で成果を上げ、その後、広告運用会社で大手クライアントのマーケティング支援に従事し、予算拡大とKPI改善に実績を残す。現在は企業の採用課題に対し、課題抽出から提案、改善施策まで一貫して担うとともに、キャリアアドバイザーとして求職者の転職支援にも携わり、企業と人材双方の成功にコミット。He achieved strong results in new business development at a major HR services company, then joined a digital advertising firm where he supported marketing initiatives for large enterprise clients, driving budget growth and KPI improvements. He currently works across the full spectrum of corporate recruitment challenges—from needs assessment and proposal development to implementing improvement measures—while also serving as a career advisor supporting job seekers in their career transitions. He is committed to delivering success for both companies and talent.

• 

  植田　杏奈 Anna Ueda Counselor

  大阪大学卒業後、大手物流企業の営業を経て心理支援の道へ転身。大阪大学大学院と米国セント・クラウド州立大学で心理学の修士号を取得し、異文化環境におけるメンタルケアの実務経験を積む。現在は、難民支援や在留外国人へのカウンセリングに加え、日本企業のビジネスパーソン向けのメンタルサポートにも従事。背景・価値観を尊重し、国籍や言語を超えて「人生に寄り添う支援」を行う。 After graduating from Osaka University, she began her career in sales at a major logistics company before transitioning into the field of psychological support. She earned master’s degrees in psychology from Osaka University Graduate School and St. Cloud State University in the United States, gaining hands-on experience in mental health care within multicultural environments. She is currently involved in refugee support and counseling for foreign residents in Japan, as well as providing mental health support for business professionals in Japanese companies. With deep respect for each individual’s background and values, she offers compassionate, person-centered support that transcends nationality and language.

• 

  清水　道浩Michihiro Shimizu Career Advisor

  帝人ファーマにて11年間、臨床開発（糖尿病・希少疾病・がん領域）に従事し、その後、新生企業投資（現 SBI グループ）でヘルスケア・IT領域のベンチャー投資を担当。イグニション・ポイント（現 電通グループ）の創業に参画し、社外取締役・COO・CFO 等として事業計画、資本政策、資金調達を実現。現在は M&A キャピタルラボ COO をはじめ、複数社で経営と事業開発に従事。He spent 11 years at Teijin Pharma working in clinical development across diabetes, rare diseases, and oncology. He then joined Shinsei Corporate Investment (now part of the SBI Group), where he led venture investments in the healthcare and IT sectors. He participated in the founding of Ignition Point (now part of the Dentsu Group), serving as Outside Director, COO, and CFO, and oversaw business planning, capital strategy, and fundraising. He is currently COO of M&A Capital Lab and is involved in management and business development across multiple companies.

• 

  神室　一翔Kazuto Kamuro Career Advisor

  米国カリフォルニア工科大学にて博士号（量子半導体工学・バイオサイエンス・IT）を取得。 日本電気株式会社（NEC）中央研究所にて13年間、主幹研究員・知的財産部執行役員として特許戦略、知財訴訟、先端技術開発に従事。 現在は米国カリフォルニア工科大学教授をはじめ、複数の研究機関で量子技術・AI・バイオコンピューティング領域の研究と知財戦略支援を行っている。He earned a Ph.D. in quantum semiconductor engineering, bioscience, and information technology from the California Institute of Technology. He spent 13 years at the NEC Central Research Laboratories as a Principal Research Scientist and Executive Officer of the Intellectual Property Division, working on patent strategy, IP litigation, and advanced technology development. He is currently a Professor at the California Institute of Technology and supports multiple research institutions in quantum technology, AI, and biocomputing, providing both research leadership and intellectual property strategy.

• 

  宮川 隆Ryu Miyagwa Career Advisor

  名古屋市立大学薬学部を卒業後、米国南カリフォルニア大学 (USC) で国際薬学臨床研修を修了。さらに東京大学大学院で理学博士号を取得し、その後は東京大学附属病院などで放射線治療・腫瘍診断の研究・臨床に従事。現在は東京科学大学特任准教授として、放射線安全管理およびがん放射線治療のためのバイオマーカー研究、放射性医薬品開発、安全教育・講師活動に幅広く取り組んでいる。After graduating from the Faculty of Pharmaceutical Sciences at Nagoya City University, he completed an international clinical pharmacy training program at the University of Southern California (USC). He went on to earn a Ph.D. in Science from the University of Tokyo and subsequently engaged in research and clinical work in radiation therapy and cancer diagnostics at the University of Tokyo Hospital and related institutions. He is currently a Specially Appointed Associate Professor at the Tokyo University of Science, where he conducts extensive work in radiation safety management, biomarker research for cancer radiotherapy, radiopharmaceutical development, and safety education and training.

Information

会社概要